Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T138067 vs Doxorubicin in HCC
NCT00057382Phase 3Terminated
- Sponsor
- Tularik Inc.
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of batabulin in hepatocellular carcinoma (HCC), sponsored by Tularik Inc.. Started Mar 2003; status: terminated.
02
Drugs
batabulin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00057382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057382.